-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Promoting Minorities in Hematology (PMH) Oral Presentations: Room III (for in-person participants)

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI)
Saturday, December 9, 2023: 6:30 PM-8:00 PM
Marina Ballroom F (Marriott Marquis San Diego Marina)
ASH invites all interested meeting attendees to this event, which will showcase training and research opportunities geared toward increasing the diversity scholars in the field of hematology. The highlight of the session will be scientific presentations from the ASH Minority Medical Student Award, the ASH Minority Resident Hematology Award, the ASH Minority Hematology Graduate Award, and the ASH Minority Hematology Fellowship Award program participants.

A special reception celebrating the 20th anniversary of the Minority Recruitment Initiative (MRI) will follow presentations.

A Standardized Approach to Screening for Academic Challenges Among Patients with Sickle Cell Disease

Alexis Rae Williams, MD

Boston Children's Hospital, Boston, MA
COVID-19 Vaccination Hesitancy in Adults with Sickle Cell Disease​

Ashley Inez Thrower, BS

Duke University Medical Center, Durham, NC
Addressing Reproductive Education Among Young Adults with Sickle Cell Disease (SCD): Sickle Cell Reproductive Outreach and Education (ROE) Project

Bria Carrithers, MD

Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL
Clinical Outcomes of Patients Referred for Asymptomatic Neutropenia: A Focus on Racial Disparities in Hematology

Emmanuella Oyogoa, DO

Oregon Health & Science University, Portland, OR
Assessing Primary Stroke Prevention Barriers and Facilitators in Children with Sickle Cell Anemia in Puerto Rico: A Mixed-Methods Study Design

Gabriela Ramirez Cuebas, MD

Department of Pediatrics, University of Puerto Rico School of Medicine, San Juan, PR
Neighborhood Disadvantage Increases Risk of Adverse Clinical Events in Children with Sickle Cell Disease

Ijele Adimora, MD, MBA

The Johns Hopkins University School of Medicine, Baltimore, MD
Creatinine-Based Estimating Equations for GFR Outperform Cystatin C-Based Equations in Adults with Sickle Cell Disease

Mauricio Barreto, MD

Children’s National Hospital, Washington, DC
Factors Associated with Severity and Poor Outcomes in COVID-19 Infection in Patients with Sickle Cell Disease: A Single-Institution Experience

Nosakhare Paul Ilerhunmwuwa, MBBS, MSc

Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
Risk Factors for Thrombosis in Pregnant People with Sickle Cell Disease: A Multinational Study

Sacha Choupa

Meharry Medical College School of Medicine, Nashville, TN
Experiences of Menopause in Women with Sickle Cell Disease

Yaa Ofori-Marfoh, MSc, BS

Rush Medical College of Rush University, Durham, NC
See more of: Special-Interest Sessions
<< Previous Session | Next Session >>